We found that the vaccine resulted in a five-fold reduction in infections by viruses carrying F317X compared to infections with viruses with F 317 (p = 0.040); there was a borderline significant two-fold reduction for viruses with I307X vs.
← all excerpts
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses.
1
—
—